Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KVD001 in Diabetic Macular Edema
NCT03466099Phase 2Completed
- Sponsor
- KalVista Pharmaceuticals
- Start
- Feb 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KVD001 in diabetic macular edema (DME), sponsored by KalVista Pharmaceuticals. Started Feb 2018; status: completed.
02
Drugs
KVD001
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03466099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03466099.